Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis.
about
Community differentiation of the cutaneous microbiota in psoriasisGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.IL-6 as a druggable target in psoriasis: focus on pustular variants.Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice.Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammationAn open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseSweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis.Signs of innate immune activation and premature immunosenescence in psoriasis patientsGranulocyte and Monocyte Adsorption Apheresis for Generalized Pustular Psoriasis: Therapeutic Outcomes in Three Refractory Patients.Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy.Apoptotic cells ameliorate chronic intestinal inflammation by enhancing regulatory B-cell function.Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis.Regulation and function of interleukin-36 cytokines.Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics.Inhibition of Inflammatory Cytokines and Induction of Myeloid-Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis.Granulocyte and monocyte apheresis can control juvenile generalized pustular psoriasis with mutation of IL36RN.Generalized Pustular Psoriasis With IL-36 Receptor Antagonist Mutation Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis Accompanied by Reduced Serum IL-6 Level.Case of generalized pustular psoriasis with end-stage renal disease successfully treated with granulocyte monocyte apheresis in combination with hemodialysis.Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.Neutrophil-to-lymphocyte ratio decreases after treatment of psoriasis with therapeutic antibodies.Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation.RNA sequencing-based longitudinal transcriptomic profiling gives novel insights into the disease mechanism of generalized pustular psoriasis.
P2860
Q21195810-FB062825-5E88-4753-841D-C928295FC67DQ30276550-84FD90CD-FE93-4D9C-8794-C038C5D0241AQ34003280-5B673338-D956-43F3-98A7-4C1069368BA3Q34008773-4714BAC2-8016-4D27-9038-3FD8B09DBF89Q34144256-F46B3065-DDB1-4D2D-82FE-3AA8C6F47910Q35071781-543813EE-2602-42C4-83F8-2648DF91D06CQ35846531-1D5C08C5-6E7B-4721-8556-0FD2C402418FQ40052767-E8AF8838-4B7C-48E5-93E0-A90D7A31C245Q40161952-7B84C57C-97FE-41A2-908A-26141FB11FA2Q41308439-AFFD801F-E232-48D3-AED2-5ED08DFC2825Q41952126-ADEFC567-606F-4B8C-8C12-B7475C4CC1A5Q43467932-04814820-1BBC-486E-A11D-BD79CD8C0EC1Q46819845-3A90E93D-5D91-4813-90CF-A01485CF6B68Q47294822-46E63DDA-B7FD-4CE1-B09E-F77C15A02756Q47298022-59C0EADF-09FB-4332-B1AB-3DD99CDEC884Q47694487-5E909724-D484-4EA0-B8E6-9C01C53322DCQ48296840-32CBF5CE-4763-47B5-8F04-5BB4B700FC82Q48301707-185A5A03-EEB1-4D16-85A5-00A58E4AF7BBQ48335028-69ABDA23-1C17-44A0-A8FE-4387ADDE3F8CQ48340900-2F3F7469-D928-4207-A117-8169C412D866Q50687774-BEB2DDFC-6C7F-43ED-B25E-D966C1FA4EFAQ52728096-440114FB-94BD-4900-A6B6-11430FD707ADQ53117222-661B1EC6-B01C-4051-A650-E49713C4AF3AQ53294714-9A529CE1-EEE2-427F-B42A-9FBDFB13600BQ55111930-263BFABE-4313-48F4-B17D-AA87917452B2Q55378699-4EB2B543-2DB2-4DF6-B15E-F8007133BD95
P2860
Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Therapeutic depletion of myelo ...... munopathogenesis of psoriasis.
@en
type
label
Therapeutic depletion of myelo ...... munopathogenesis of psoriasis.
@en
prefLabel
Therapeutic depletion of myelo ...... munopathogenesis of psoriasis.
@en
P2093
P1476
Therapeutic depletion of myelo ...... mmunopathogenesis of psoriasis
@en
P2093
Akimichi Morita
Hidetoshi Takahashi
Hikaru Eto
Kazuo Takahashi
Keiko Okuma
Mariko Seishima
Shigaku Ikeda
Takafumi Etoh
Takeshi Kanbara
Takuro Kanekura
P304
P356
10.1016/J.JAAD.2012.09.037
P407
P50
P577
2013-01-17T00:00:00Z